NLRP3 and myelodysplastic syndrome: Since an increase in MCV is a characteristic of MDS, which is also known as CHIP-related disease, it is possible that an increase in MCV reflects an increase in CHIP, causing an activation of NLRP3 inflammasome and inflammatory cytokines that results in an inflammatory condition in the liver [35].